BiotechTube
Home/Wakunaga Pharmaceutical/Hirohito Wakunaga
HW

Hirohito Wakunaga

Representative Director and President

Wakunaga Pharmaceutical

Therapeutic Areas

Cardiovascular HealthImmune SupportGeneral Wellness & Healthy Aging

Wakunaga Pharmaceutical Pipeline

DrugIndicationPhase
Kyolic/Leopin Brand ExpansionCardiovascular, Immune, Cognitive SupportCommercial
Regulatory Approval ExpansionAtherosclerosis Prevention (following German approval)Regulatory
OTC Pharmaceutical DevelopmentVarious self-care ailmentsCommercial/Development